How viral and immune treatments affect early HIV infection in the mouth

Influence of viral and immune interventions on early events following oral SIV infection

NIH-funded research Seattle Children's Hospital · NIH-10996126

This study is looking at how HIV spreads through the mouth, especially in babies born to moms with HIV and during oral sex, to find better ways to prevent infection by testing a new vaccine that goes directly into the mouth.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital NIH-funded
Lab location1 site (Seattle, United States)
Project IDNIH-10996126 on NIH RePORTER

What this research studies

This research investigates how HIV is transmitted through oral mucosal surfaces, particularly focusing on infants born to HIV-positive mothers and through oral sexual contact. It aims to understand the early events of HIV infection by using innovative techniques to deliver a vaccine directly into the oral mucosa, which may help in identifying where and how the virus enters the body. By studying the immune response in draining lymph nodes after this vaccine delivery, the research seeks to improve prevention strategies against HIV transmission. This approach could lead to better understanding and potentially new interventions for those at risk of HIV infection.

Who could benefit from this research

Good fit: Ideal candidates for this research include infants born to HIV-positive mothers and individuals at risk of HIV transmission through oral contact.

Not a fit: Patients who are not at risk of HIV infection or those who are already HIV-positive may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies for HIV transmission, particularly in vulnerable populations such as infants.

How similar studies have performed: Other research has shown promise in using innovative vaccine delivery methods for HIV prevention, indicating potential for success in this approach.

Where this research is happening

Seattle, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.